Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined Vaccine

NCT06857370 is registered in ClinicalTrials.gov with CanSino Biologics Inc. as lead sponsor.

NCT NCT06857370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06857370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined Vaccine
Lead sponsor
CanSino Biologics Inc.
Phase
Phase 3
Overall status
Active, not recruiting
Start date
March 23, 2025
Completion date
January 31, 2026
Enrollment
780 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diphtheria, tetanus and acellular pertussis